Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly S-1, Leucovorin and Gemcitabine in Elderly Pancreatic Cancer
NCT03559348Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Apr 2018
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, folinic acid, gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by National Health Research Institutes. Started Apr 2018; status: completed.
02
Drugs
tegafurfolinic acidgemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03559348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559348.